IFX-201 Investigational IL-13 antibody for moderate-to-severe atopic dermatitis, undergoing preclinical development with first-in-human studies planned for 2027.
Visit productCosigns Received
Be the first Cosign
Put your name behind IFX-201.
Add it to your Products I use list and share why you use it.